KYAN Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11337 Isleta St, Los Angeles, California...Website
www.kyantherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About KYAN Therapeutics
KYAN Therapeutics, Inc. (a Delaware Corporation headquartered in Singapore) is a biotechnology company using proprietary and patented technology to redefine how therapies are developed and offered to patients. From preclinical drug development to personalized medicine, KYAN offers powerful solutions with its optimization of drug-dose combinations. Using a novel approach that employs efficient experiments and complex, small data analytics to drive its computational core, KYAN has identified safe and effective therapies in various cancers. An assay deployed by KYAN in clinical studies has successfully personalized combination therapies for over 67 lymphoma patients who failed multiple lines of standard of care.Explore more
KYAN Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KYAN Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on KYAN Therapeutics recently announced quarterly report
Check out if KYAN Therapeutics is spiking on competitors!
KYAN Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if KYAN Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once KYAN Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when KYAN Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at KYAN Therapeutics
Check if KYAN Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to KYAN Therapeutics
Compare insights from companies similar to KYAN Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
KYAN Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
KYAN Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about KYAN Therapeutics.
KYAN Therapeutics Tech Stack
A closer look at the technologies used by KYAN Therapeutics
KYAN Therapeutics News & Media
KYAN Therapeutics Announces Presentation of Clinical Utility of Ex-Vivo Platform at ASTRO and CTOS by Collaborators
SINGAPORE, October 6, 2022 /EINPresswire.com/ -- Data on the feasibility of identifying therapeutic options in head and neck cancers and sarcoma with KYAN’s analytical ex vivo drug screening platform will be presented at the Annual Meetings of the …KYAN Therapeutics' technology platform identifies novel and effective nucleic acid therapies for MYC-driven liver cancer
Study published in Bioengineering & Translational Medicine SINGAPORE, SINGAPORE, September 17, 2022 /EINPresswire.com/ -- MYC is a transcription factor that is dysregulated in over 70% of human cancers, making it an important target that …KYAN Therapeutics and Curie Oncology Announce Strategic Collaboration to Provide Personalized Cancer Test in Singapore
KYAN Therapeutics uses small data AI in a proprietary phenotypic drug sensitivity assay to guide patient treatment for cancer patients with high and unmet needs SINGAPORE, May 9, 2022 /EINPresswire.com/ -- KYAN Therapeutics teams up with Curie Oncology …KYAN Therapeutics and Aesculape CRO Partner to Offer Drug Development Biopharma Services
SINGAPORE, April 28, 2022 /EINPresswire.com/ -- KYAN Therapeutics, Inc. (KYAN) and Aesculape CRO (Aesculape) announce plans to offer drug development optimization services for Pharmaceutical and Biotech companies. Studies in recent years estimate that …
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KYAN Therapeutics
Sign Up For FreeTo access detailed company insights
KYAN Therapeutics, Inc. (a Delaware Corporation headquartered in Singapore) is a biotechnology company using proprietary and patented technology to redefine how therapies are developed and offered to patients. From preclinical drug development to personalized medicine, KYAN offers powerful solutions with its optimization of drug-dose combinations.... Read More
